SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-059998
Filing Date
2023-12-29
Accepted
2023-12-29 16:22:14
Documents
1
Period of Report
2023-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3745
  Complete submission text file 0001209191-23-059998.txt   5234
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O RELAY THERAPEUTICS, INC. 399 BINNEY STREET CAMBRIDGE MA 02139
Business Address
Catinazzo Thomas (Reporting) CIK: 0001818261 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39385 | Film No.: 231527967